FOR IMMEDIATE RELEASE: February 12, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Awardee Has Remained at the Vanguard of Various Cancer Immunotherapy Fields for over Four Decades ROCKVILLE, MD – The National Foundation for Cancer Research…...
Anti-Cancer Properties Found in a Deadly Australian Arachnid
Identified as the deadliest arachnid in the world, a bite from the Australian funnel web spider can result in death in as little as fifteen minutes. However, according to recent findings, the venom of the funnel web spider may have curative properties when treating human melanoma cells. The survival of…...
National Foundation for Cancer Research Announces Leadership Transition
FOR IMMEDIATE RELEASE: February 8, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – The National Foundation for Cancer Research (NFCR) today announced the promotion of Sujuan Ba, Ph.D., to president and chief executive officer.…...
Cancer and Genomics: A Primer
In 2017, genetic researchers in the United Kingdom introduced a powerful new mechanical tool in the growing field of genomics which may guide the way to new cancer treatments. The high-tech genome sequencer, the Illumina NovaSeqTM 6000, was unveiled at The Institute of Cancer Research (the ICR) in London. “It…...
World Cancer Day: How Far We’ve Come
For the past two decades, people around the globe have bound together to promote cancer awareness every February 4th, World Cancer Day. The National Foundation for Cancer Research is honored to be one of over a thousand members of the Day’s coordinator, the Swiss-based Union for International Cancer Control (UICC).…...
Breast Cancer Linked to Bone Marrow Cells
“Our study shows that the recruitment of bone marrow-derived fibroblasts is important for promoting tumor growth, likely by enhancing blood vessel formation,” says Dr. Neta Erez of the Sackler School of Medicine at Tel Aviv University, discussing a recent discovery finding that breast cancer can “recruit” stromal cells originally formed…...
“Pink Drink” to Aid Brain Tumor Treatment
Approved in June 2017 by the U.S. Food and Drug Administration and launched commercially in-country in October 2018, 5-Aminolevulinic Acid (also known as 5-ALA, and composed of aminolevulinic acid hydrochloride) is an optical imaging agent for use in patients with high-grade gliomas. Nicknamed the “pink drink,” 5-ALA is a surgical…...
Faces & Voices of Cancer–In Depth: Maureen Kenner
Maureen Kenner was known in the Providence, Rhode Island community for the relationships she had with her students and their families. A special education elementary teacher for 35 years, she was recognized as Providence Teacher of the Year in 2003 for being a compassionate and devoted educator. In 2014, Maureen…...
Strategic Media Partner
